The aminobarbituric acid-hydantoin rearrangement

被引:50
作者
Meusel, M
Ambrozak, A
Hecker, TK
Gütschow, M
机构
[1] Univ Bonn, Inst Pharmaceut, D-53115 Bonn, Germany
[2] Univ Leipzig, Inst Pharm, D-04103 Leipzig, Germany
关键词
D O I
10.1021/jo020761f
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A general synthesis protocol for the generation of tri- and tetrasubstituted 5-carbamoylhydantoins is described. Starting from barbituric acids and following bromination and reaction with primary amines, 5-aminobarbituric acids 3a-s and 8 were prepared. Compounds 3 and 8 were subjected to different conditions of a base-catalyzed rearrangement reaction to yield the 1,5,5-trisubstituted hydantoins 4a-s and the 1,3,5,5-tetrasubstituted hydantoin 5c, respectively. Alkylation of 4a-s afforded 1,3,5,5-tetrasubstituted hydantoins 5a-h. Mechanisms that explain the transformation of corresponding aminobarbituric acids to hydantoins 4a-s and 5c were discussed in terms of the formation of ring-opened intermediates. Aminobarbituric acids 3a-s unsubstituted at position 3 underwent a ring contraction via intermediate isocyanates which were trapped by the amino function. A different mechanism involving a carbamate intermediate was concluded for conversion of the 1,3,5,5-tetrasubstituted aminobarbituric acid 8.
引用
收藏
页码:4684 / 4692
页数:9
相关论文
共 69 条
[1]  
ANTEUNIS MJO, 1987, B SOC CHIM BELG, V96, P459
[2]  
ASPELUND H, 1939, ACTA ACADEMIAE ABOEN, V12, P1
[3]  
Barton HJ, 1996, POL J CHEM, V70, P570
[4]  
Bazil CW, 1998, ANNU REV MED, V49, P135
[5]  
Beller M, 1999, ANGEW CHEM INT EDIT, V38, P1454, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1454::AID-ANIE1454>3.0.CO
[6]  
2-D
[7]   Combinatorial chemistry of hydantoins [J].
Boeijen, A ;
Kruijtzer, JAW ;
Liskamp, RMJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (17) :2375-2380
[8]   RECENT PROGRESS IN BARBITURIC-ACID CHEMISTRY [J].
BOJARSKI, JT ;
MOKROSZ, JL ;
BARTON, HJ ;
PALUCHOWSKA, MH .
ADVANCES IN HETEROCYCLIC CHEMISTRY, 1985, 38 :229-297
[9]  
BULT A, 1975, PHARM WEEKBLAD, V110, P1161
[10]  
Byrtus H, 2001, POL J PHARMACOL, V53, P395